Edition:
United States

Emblem Corp (EMC.V)

EMC.V on TSX Venture Exchange

1.74CAD
11 Dec 2017
Change (% chg)

-- (--)
Prev Close
$1.74
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
553,425
52-wk High
$4.60
52-wk Low
$1.47

Chart for

About

Emblem Corp, formerly Saber Capital Corp., is a Canada-based producer and distributor of medical cannabis and cannabis derivatives licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR). The Company offers fully integrated services covering the full cannabis spectrum, from growing to selling, as well as... (more)

Overall

Beta: --
Market Cap(Mil.): $138.56
Shares Outstanding(Mil.): 79.63
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.83 15.71
EPS (TTM): -- -- --
ROI: -- 15.03 31.93
ROE: -- 16.54 16.16

BRIEF-Emblem Announces Qtrly ‍net Loss Per Share C$0.03​

* EMBLEM CORP - QTRLY ‍NET LOSS PER SHARE C$0.03​ Source text for Eikon: Further company coverage:

Nov 28 2017

BRIEF-EMBLEM RECEIVES HEALTH CANADA LICENSE TO SELL CANNABIS EXTRACTS

* EMBLEM RECEIVES HEALTH CANADA LICENSE TO SELL CANNABIS EXTRACTS Source text for Eikon: Further company coverage:

Nov 06 2017

BRIEF-EMBLEM APPOINTS NICK DEAN AS CHIEF EXECUTIVE OFFICER

* ‍DEAN SUCCEEDS GORDON H. FOX​ Source text for Eikon: Further company coverage:

Oct 30 2017

BRIEF-Emblem announces increase in bought deal offering to $12 million

* Emblem announces increase in bought deal offering to $12 million

Oct 17 2017

BRIEF-Emblem announces $25 mln bought deal

* Emblem - to use net proceeds of offering for construction of first 100,000 sq. ft. Production facility on 80 acre property located in Paris, Ontario​

Oct 16 2017

BRIEF-Emblem announces exclusive agreement with Canntab Therapeutics

* Emblem announces exclusive agreement with Canntab Therapeutics for cannabinoid based oral sustained release formulation Source text for Eikon: Further company coverage:

Oct 03 2017

BRIEF-Emblem announces Q2 net loss per share $0.03

* Emblem Corp - Qtrly net loss per share $0.03 Source text for Eikon: Further company coverage:

Aug 28 2017

Earnings vs. Estimates